Cargando…
Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period
(1) Background: Malignant tumours of the salivary glands have different clinical and histopathological characteristics. They most commonly involve the parotid gland. Histopathologically, the most common are mucoepidermoid carcinoma (MEC), adenoid cystic carcinoma (AdCC), acinic cell carcinoma (AcCC)...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408518/ https://www.ncbi.nlm.nih.gov/pubmed/36011881 http://dx.doi.org/10.3390/ijerph191610247 |
_version_ | 1784774620825518080 |
---|---|
author | Żurek, Michał Jasak, Kamil Jaros, Karolina Daniel, Piotr Niemczyk, Kazimierz Rzepakowska, Anna |
author_facet | Żurek, Michał Jasak, Kamil Jaros, Karolina Daniel, Piotr Niemczyk, Kazimierz Rzepakowska, Anna |
author_sort | Żurek, Michał |
collection | PubMed |
description | (1) Background: Malignant tumours of the salivary glands have different clinical and histopathological characteristics. They most commonly involve the parotid gland. Histopathologically, the most common are mucoepidermoid carcinoma (MEC), adenoid cystic carcinoma (AdCC), acinic cell carcinoma (AcCC), adenocarcinoma, carcinoma in pleomorphic adenoma (CPA), and squamous cell carcinoma (SCC). (2) Methods: We analysed 2318 patients with malignant parotid gland tumours reported to the National Cancer Registry (NCR) in Poland over 20 years (1999–2018). The demographic characteristics of patients, clinical factors, and overall survival (OS) were analysed. (3) Results: The average age was 61.33 ± 16.1 years. The majority were males (55%) and urban citizens (64%). High percentage of carcinomas was diagnosed in locoregional (33.7%) and systemic (10.4%) stadium. The most prevalent diagnoses were SCC (33.3%) and adenocarcinoma (19.6%). Surgical resection with adjuvant RT (42.1%) was the most common treatment. The OS analysis showed a median survival time of 5.6 years. The most favorable median OS was found in patients with AcCC (18.30 years), the worst for SCC (1.58 years). (4) Conclusion: AcCC has the best prognosis and SCC the worst. Tumour stadium, treatment, and demographic factors affect prognosis. Improvements in diagnosis and re-evaluation of treatment standards are necessary to enhance the outcome of patients with parotid gland cancers in Poland. |
format | Online Article Text |
id | pubmed-9408518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94085182022-08-26 Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period Żurek, Michał Jasak, Kamil Jaros, Karolina Daniel, Piotr Niemczyk, Kazimierz Rzepakowska, Anna Int J Environ Res Public Health Article (1) Background: Malignant tumours of the salivary glands have different clinical and histopathological characteristics. They most commonly involve the parotid gland. Histopathologically, the most common are mucoepidermoid carcinoma (MEC), adenoid cystic carcinoma (AdCC), acinic cell carcinoma (AcCC), adenocarcinoma, carcinoma in pleomorphic adenoma (CPA), and squamous cell carcinoma (SCC). (2) Methods: We analysed 2318 patients with malignant parotid gland tumours reported to the National Cancer Registry (NCR) in Poland over 20 years (1999–2018). The demographic characteristics of patients, clinical factors, and overall survival (OS) were analysed. (3) Results: The average age was 61.33 ± 16.1 years. The majority were males (55%) and urban citizens (64%). High percentage of carcinomas was diagnosed in locoregional (33.7%) and systemic (10.4%) stadium. The most prevalent diagnoses were SCC (33.3%) and adenocarcinoma (19.6%). Surgical resection with adjuvant RT (42.1%) was the most common treatment. The OS analysis showed a median survival time of 5.6 years. The most favorable median OS was found in patients with AcCC (18.30 years), the worst for SCC (1.58 years). (4) Conclusion: AcCC has the best prognosis and SCC the worst. Tumour stadium, treatment, and demographic factors affect prognosis. Improvements in diagnosis and re-evaluation of treatment standards are necessary to enhance the outcome of patients with parotid gland cancers in Poland. MDPI 2022-08-18 /pmc/articles/PMC9408518/ /pubmed/36011881 http://dx.doi.org/10.3390/ijerph191610247 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Żurek, Michał Jasak, Kamil Jaros, Karolina Daniel, Piotr Niemczyk, Kazimierz Rzepakowska, Anna Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period |
title | Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period |
title_full | Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period |
title_fullStr | Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period |
title_full_unstemmed | Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period |
title_short | Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period |
title_sort | clinico-epidemiological analysis of most prevalent parotid gland carcinomas in poland over a 20-year period |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408518/ https://www.ncbi.nlm.nih.gov/pubmed/36011881 http://dx.doi.org/10.3390/ijerph191610247 |
work_keys_str_mv | AT zurekmichał clinicoepidemiologicalanalysisofmostprevalentparotidglandcarcinomasinpolandovera20yearperiod AT jasakkamil clinicoepidemiologicalanalysisofmostprevalentparotidglandcarcinomasinpolandovera20yearperiod AT jaroskarolina clinicoepidemiologicalanalysisofmostprevalentparotidglandcarcinomasinpolandovera20yearperiod AT danielpiotr clinicoepidemiologicalanalysisofmostprevalentparotidglandcarcinomasinpolandovera20yearperiod AT niemczykkazimierz clinicoepidemiologicalanalysisofmostprevalentparotidglandcarcinomasinpolandovera20yearperiod AT rzepakowskaanna clinicoepidemiologicalanalysisofmostprevalentparotidglandcarcinomasinpolandovera20yearperiod |